Ventricular fibrillation, hypokalemia, and AMSA therapy.
D000328:Adult; D000585:Aminacrine / Q000009:adverse effects* / Q000031:analogs & derivatives; D000609:Aminoacridines / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D014693:Ventricular Fibrillation / Q000139:chemically induced*
D000609:Aminoacridines; D000970:Antineoplastic Agents; D000585:Aminacrine; C013389:4'-(9-acridinylamino)methanesulfonanilide